| Mr. Patrick Walsh |
Independent Chairman of the Board |
62 |
$415.5K - USD |
Male |
|
| Mr. Nikhil Lalwani |
President, Chief Executive Officer, Director |
45 |
$5.112M - USD |
Male |
|
| Mr. Stephen Carey |
Chief Financial Officer, Senior Vice President |
52 |
$2.040M - USD |
Male |
|
| Ms. Krista Davis |
Chief Human Resource Officer |
50 |
- |
Female |
|
| Ms. Meredith Cook |
Senior Vice President, General Counsel, Company Secretary |
|
- |
Female |
|
| Mr. Chad Gassert |
Senior Vice President - Corporate Development and Strategy |
47 |
- |
Male |
|
| Mr. Ori Gutwerg |
Senior Vice President - Generics |
49 |
$1.363M - USD |
Male |
|
| Mr. James Marken |
Senior Vice President - Operations |
60 |
$1.431M - USD |
Male |
|
| Mr. Christopher Mutz |
Senior Vice President, Head of Rare Diseases |
52 |
$1.304M - USD |
Male |
|
| Mr. Muthusamy Shanmugam |
Director, Head of Research and Development, Chief Operating Officer - Novitium Operations |
55 |
- |
Male |
|
| Mr. Matthew Leonard |
Director |
57 |
- |
Male |
|
| Mr. Thomas Haughey |
Independent Director |
59 |
$395.9K - USD |
Male |
|
| Dr. David Nash |
Independent Director |
67 |
$390.9K - USD |
Male |
|
| Mr. Antonio Pera |
Independent Director |
65 |
$373.4K - USD |
Male |
|
| Dr. Renee Tannenbaum |
Independent Director |
71 |
$395.7K - USD |
Female |
|
| Ms. Jeanne Thoma |
Independent Director |
64 |
$375.9K - USD |
Female |
|
| Ms. Lisa Wilson |
Investor Relations |
|
- |
Female |
|
